Immune checkpoint inhibitors can be effective treatments for elderly people with some types of advanced cancer, but more information is needed on their risks and benefits in this group.

by Emma Yasinski

Research shows prominent cancer hospitals have different surgical outcomes than their affiliates.

by Marci A. Landsmann

Patients diagnosed with low-risk prostate cancer are increasingly opting against immediate surgery or radiation in favor of regularly monitoring their disease.

by Jon Kelvey

A study investigates whether a commonly used clinical trial endpoint, progression-free survival, can be used to predict quality of life.

by Jon Kelvey